Nuvectis Pharma, Inc. (NVCT)

NASDAQ: NVCT · Real-Time Price · USD

20.24

+0.01 (0.05%)

Nov 13, 2026, 4:00 PM EST - Market closed

Nuvectis Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	140.71	31.63	18.53	19.13	19.99	5.74
Cash & Short-Term Investments	140.71	31.63	18.53	19.13	19.99	5.74
Cash Growth	297.01%	70.69%	-3.10%	-4.34%	248.19%	-
Other Current Assets	0.13	0.08	0.07	0.06	0.41	0.09
Total Current Assets	140.84	31.71	18.61	19.19	20.41	5.83
Long-Term Deferred Charges	-	-	-	-	-	0.82
Total Assets	140.84	31.71	18.61	19.19	20.41	6.66

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	5.76	6.27	2.5	2.77	2.91	1.06
Accrued Expenses	8.43	7.02	6.4	4.21	2.83	0.54
Other Current Liabilities	-	-	-	-	0.45	0.82
Total Current Liabilities	14.19	13.3	8.89	6.98	6.19	2.42
Total Liabilities	14.19	13.3	8.89	6.98	6.19	2.42

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Additional Paid-In Capital	269.47	118.1	82.96	66.45	46.2	1.89
Retained Earnings	-142.83	-99.69	-73.25	-54.25	-31.99	-12.9
Total Common Equity	126.65	18.41	9.71	12.2	14.22	-11.01
Shareholders' Equity	126.65	18.41	9.71	12.2	14.22	4.24
Total Liabilities & Equity	140.84	31.71	18.61	19.19	20.41	6.66

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Cash (Debt)	140.71	31.63	18.53	19.13	19.99	5.74
Net Cash Growth	297.01%	70.69%	-3.10%	-4.34%	248.19%	-
Net Cash Per Share	5.65	1.45	1.08	1.23	1.58	1.35
Filing Date Shares Outstanding	34.39	26.49	23.39	17.77	14.75	12.72
Total Common Shares Outstanding	34.39	25.68	19.5	17.42	14.64	4.51
Working Capital	126.65	18.41	9.71	12.2	14.22	3.41
Book Value Per Share	3.68	0.72	0.50	0.70	0.97	-2.44
Tangible Book Value	126.65	18.41	9.71	12.2	14.22	-11.01
Tangible Book Value Per Share	3.68	0.72	0.50	0.70	0.97	-2.44

SEC Filings: 10-K · 10-Q